A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.
| Author | |
|---|---|
| Abstract |
:
Open trials suggest phentermine/topiramate ER (PHEN/TPM-ER), food and drug administration (FDA) approved for obesity, has utility for binge eating. With no randomized controlled trials (RCTs) yet performed, this trial aimed to evaluate PHEN/TPM-ERs efficacy and safety in a crossover RCT for patients with binge-eating disorder (BED) or bulimia nervosa (BN). |
| Year of Publication |
:
2020
|
| Journal |
:
The International journal of eating disorders
|
| Volume |
:
53
|
| Issue |
:
2
|
| Number of Pages |
:
266-277
|
| ISSN Number |
:
0276-3478
|
| URL |
:
https://doi.org/10.1002/eat.23192
|
| DOI |
:
10.1002/eat.23192
|
| Short Title |
:
Int J Eat Disord
|
| Download citation |
